Q&A: Insights From a Long-Running Study of Alzheimer’s Risk
In our LiveTalk series, Being Patient explored the inner workings of the Wisconsin Registry for Alzheimer’s Prevention, a long-running study of people at risk…
In our LiveTalk series, Being Patient explored the inner workings of the Wisconsin Registry for Alzheimer’s Prevention, a long-running study of people at risk…
Targeting beta-amyloid protein before symptoms of cognitive decline or Alzheimer’s appear is the goal of one trial out of the National Institute on Aging…
When it comes to Alzheimer’s, what happens first: beta amyloid plaques, or the visible personality and cognitive changes common with the disease? Researchers have…
Neurodegenerative diseases like Alzheimer’s and dementia are caused by specific protein clumps — like tau or amyloid buildup. But researchers are still investigating how…
Scientists have largely focused on the buildup of beta-amyloid as one of the major drivers of Alzheimer’s disease, but more and more research is…
Researchers are partnering with NASA to develop a new experiment that will test how amyloid protein clusters—one of the biological markers of Alzheimer’s—form. Known…
One of the most pressing mysteries of Alzheimer’s disease and other dementias is how long—and where—amyloid plaques have been developing, before the disease becomes…